How does FDA interact with CLIA?

The FDA determines the complexity categorization of laboratory tests, which then dictates the specific CLIA requirements a laboratory must meet.

Does CLIA apply to tests performed outside of a traditional laboratory setting?

Yes, CLIA applies to all facilities in the United States that perform tests on human specimens for diagnosis, prevention, or treatment of disease, including point-of-care settings.

All terms

Market SegmentsClinical Evidence Strategic LandscapeCLIA

Clinical Laboratory Improvement Amendments

U.S. federal standards that govern clinical laboratory testing.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

CLIA establishes quality standards for all U.S. laboratory testing performed on humans. Labs are certified by complexity (waived, moderate, high) and inspected by CMS or accreditation organizations (CAP, COLA, Joint Commission). CLIA categorizes tests as waived, moderate complexity or high complexity, and labs must hold the matching certificate. CMS runs the program, FDA categorizes tests and CDC supports quality standards. Labs face proficiency testing, personnel requirements and inspections.

What the regulation says

CLIA, codified in 42 CFR 493, establishes federal standards for all laboratory testing performed on human specimens in the United States, except for research not involving patient-specific results. The Centers for Medicare & Medicaid Services (CMS) regulates CLIA, ensuring accuracy, reliability, and timeliness of patient test results regardless of where the test is performed. The FDA categorizes tests by complexity, influencing CLIA certification requirements.

What this means in practice

Moderate/high-complexity certification is required for most molecular and oncology testing. CLIA waiver is the gold standard for point-of-care market expansion.

Examples

A manufacturer designing a new in vitro diagnostic (IVD) device seeks FDA classification as "waived" to simplify regulatory burdens for end-users.
A hospital laboratory upgrading its pathology services must ensure all new tests and equipment comply with high-complexity CLIA regulations, including personnel qualifications and quality control.
A MedTech company developing an AI-powered diagnostic algorithm ensures that its validation protocols align with CLIA requirements for analytical validity and clinical validity.

Common pitfalls

•Misinterpreting "CLIA waived" as exempt from all regulatory oversight; waived tests still have specific conditions.
•Failing to properly document personnel qualifications for moderate and high complexity testing.
•Overlooking the need for a CLIA certificate even if performing a limited number of tests.
•Assuming that accreditation by an organization like CAP or COLA negates the need for CLIA compliance.

Frequently asked questions

CLIA ensures the accuracy, reliability, and timeliness of laboratory test results, aiming to safeguard public health.

Cross-references

Governs

Things this term applies rules or requirements to.

Laboratory-Developed Test(LDT)

Grouped by theme

Editor's picks

· Hand-selected related concepts

Market Segments

Laboratory-Developed Test(LDT)

IVD designed, manufactured, and used within a single CLIA laboratory.

Market Segments

Point-of-Care Diagnostics(POC)

Diagnostic tests performed near the patient, outside a central lab.

More in Market Segments

· Same category

Market Segments

Aesthetic & Energy-Based Devices

Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.

Market Segments

AI Imaging Software

Software that analyzes medical images to triage, detect, or quantify disease.

Market Segments

Cardiac Rhythm Management(CRM)

Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.

Market Segments

Cardiovascular Devices

Devices for diagnosing, monitoring, or treating cardiovascular disease.

Cited by

Where this term appears across MedTech Terms.

Ecosystems (2)

Latest in MedTech

Sources

3 sources

Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 2

Link health: 3 verified· last checked 2026-06-20

CMS·1MedTech Europe·1MedTech Dive·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Market Segments0 / 38

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Market Segments
Acronym: CLIA
Sources: 3
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

U.S. federal standards that govern clinical laboratory testing.

·Moderate/high-complexity certification is required for most molecular and oncology testing.
·CLIA waiver is the gold standard for point-of-care market expansion.
·laboratory testing performed on humans.

Remember this

Watch out: Misinterpreting "CLIA waived" as exempt from all regulatory oversight; waived tests still have specific conditions.

Related terms

You may also need

Auto-suggested from Market Segments and shared keywords.

All Market Segments terms